Skip to content

Is the Evaluation of Anal Distensibility by Endoflip® Technique Useful for the Diagnosis of Anismus?

Is the Evaluation of Anal Distensibility by Endoflip® Technique Useful for the Diagnosis of Anismus?

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04155307
Acronym
Endo-DC
Enrollment
61
Registered
2019-11-07
Start date
2020-01-14
Completion date
2024-05-21
Last updated
2025-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anismus, Distal Constipation

Brief summary

Terminal constipation affects 13 to 20% of the french population. Anismus is defined by an absence of relaxation or a paradoxical contraction of the striated anal sphincter muscle during defecation. Anismus is one of the main causes of terminal constipation. Anismus diagnosis is retained if 2 out of 3 examinations (manometry, electromyogram, defecography) are positive. EndoFLIP® is a new medical device developed to measure distensibility of a hollow organ. Anal EndoFLIP® l could be a more sensitive and specific tool for detecting anismus in patients with distal constipation. 60 patients suffering from distal constipation will be included in order to perform, in addition to the usual examinations, an anal EndoFlip in order to test the sensitivity and specificity of this method for the diagnosis of anismus.

Interventions

DEVICEAnal EndoFLIP®

Anal EndoFLIP® measure to evaluate anal compliance

DIAGNOSTIC_TESTAnal Manometry

Anal Manometry done in standard care

DIAGNOSTIC_TESTDefecography

Defecographydone in standard care

DIAGNOSTIC_TESTElectromyogram

Electromyogram done in standard care

Sponsors

University Hospital, Rouen
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patient older than 18 years * patient with distal constipation defined according to the Rome IV criteria, for at least 3 months and verified by a transit time study showing a predominant slowing of markers at the recto-sigmoid level. * patient who read and signed the informed consent form

Exclusion criteria

* Patients with a predominant right of left colonic constipation; * Pregnant woman or woman with no effective contraception and of childbearing age * Patient with inflammatory bowel disease, ischemic colitis, history of colon or rectal cancer, infectious colitis or proctologic disease. * Patient with anorectal malformation * Patient with an history of pelvic floor radiotherapy * Patient with a digestive stoma * Insertion of the probe impossible or painful * Patient who has participated to a clinical trial within 30 days prior to the inclusion visit * Patient not understanding or reading French * Patients under guardianship, curatorship, safeguard of justice * Patient without liberty by administrative or judicial decision

Design outcomes

Primary

MeasureTime frame
Sensitivity of the anal distensibility evaluated with the EndoFLIP® technique for the diagnosis of anismus30 min
Specificity of the anal distensibility evaluated with the EndoFLIP® technique for the diagnosis of anismus30 min

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026